Dorsey, Jay F <br/><br/>
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells.  [electronic resource] 

 -  Molecular cancer therapeutics  Dec 2009 
 - 3285-95 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-09-0415  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Blotting, Western<br/>Brain Neoplasms--drug therapy<br/>Caspases--metabolism<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Drug Synergism<br/>Fluorodeoxyglucose F18<br/>Glioblastoma--drug therapy<br/>Humans<br/>Luminescent Measurements<br/>Mice<br/>Mice, Nude<br/>Paclitaxel--administration & dosage<br/>Positron-Emission Tomography--methods<br/>TNF-Related Apoptosis-Inducing Ligand--administration & dosage<br/>Treatment Outcome<br/>Tumor Burden--drug effects<br/>Tumor Suppressor Protein p53--genetics<br/>X-Ray Microtomography--methods<br/>Xenograft Model Antitumor Assays